CEPHEID 4

Accession 0001209191-15-065316

CIK 0001037760operating

Filed

Aug 10, 8:00 PM ET

Accepted

Aug 11, 5:21 PM ET

Size

28.2 KB

Accession

0001209191-15-065316

Form 4

Period: 2015-08-07

SVP Clinical Affairs & Reg Sub

Transactions

Exercise/Conversion
Common Stock
2015-08-07$35.48/sh+9,584$340,040→ 57,956 total
Exercise/Conversion
Non-qualified Stock Option (Right to Buy)
2015-08-07−9,584→ 4,792 total
Exercise: $35.48Exp: 2020-01-02→ Common Stock (9,584 underlying)
Exercise/Conversion
Common Stock
2015-08-07$31.48/sh+4,267$134,346→ 7,048 total
Exercise/Conversion
Common Stock
2015-08-07$45.84/sh+12,890$590,878→ 45,066 total
Sale
Common Stock
2015-08-07$51.10/sh−54,008$2,759,798→ 67,540 total
Exercise/Conversion
Non-qualified Stock Option (Right to Buy)
2015-08-07−4,267→ 0 total
Exercise: $31.48Exp: 2018-04-25→ Common Stock (4,267 underlying)
Exercise/Conversion
Non-qualified Stock Option (Right to Buy)
2015-08-07−4,220→ 4,219 total
Exercise: $35.72Exp: 2019-04-24→ Common Stock (4,220 underlying)
Exercise/Conversion
Non-qualified Stock Option (Right to Buy)
2015-08-07−12,890→ 28,360 total
Exercise: $45.84Exp: 2021-04-21→ Common Stock (12,890 underlying)
Exercise/Conversion
Common Stock
2015-08-07$38.66/sh+29,531$1,141,668→ 15,535 total
Sale
Common Stock
2015-08-11$51.39/sh−2,202$113,161→ 0 total
Exercise/Conversion
Non-qualified Stock Option (Right to Buy)
2015-08-07−29,531→ 22,969 total
Exercise: $38.66Exp: 2020-04-29→ Common Stock (29,531 underlying)
Exercise/Conversion
Common Stock
2015-08-07$35.72/sh+4,220$150,738→ 11,315 total
Sale
Common Stock
2015-08-07$51.85/sh−11,330$587,458→ 2,202 total

Footnotes (5)

[F1]The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person.
[F2]The total reflects 30,000 RSUs granted on April 27, 2015 rescinded pursuant to an agreement between the Issuer and Reporting Person.
[F3]The sales price reported is the weighted average sale price for the number of shares sold. Full information regarding the number of shares sold at each separate price will be supplied upon request by the Securities & Exchange Commission staff, the Issuer or a security holder of the Issuer.
[F4]25% of the shares subject to the grant vest and become exercisable on the one-year anniversary of the grant date, then 2.0833% of the shares subject to the grant vest and become exercisable each month thereafter, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.
[F5]1/3 of the shares subject to the grant vest and become exercisable on the first anniversary of the grant date then 1/36th of the shares subject to the grant vest and become exercisable each month thereafter, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date.

Documents

1 file

CEPHEID

CIK 0001037760

Entity typeoperating

IncorporatedCA